Bio-Rad Laboratories - 15 Year Stock Price History | BIO
Historical daily share price chart and data for Bio-Rad Laboratories since 2011 adjusted for splits and dividends. The latest closing stock price for Bio-Rad Laboratories as of September 17, 2026 is 382.41.
- The all-time high Bio-Rad Laboratories stock closing price was 825.77 on September 02, 2021.
- The Bio-Rad Laboratories 52-week high stock price is 396.23, which is 3.6% above the current share price.
- The Bio-Rad Laboratories 52-week low stock price is 236.73, which is 38.1% below the current share price.
- The average Bio-Rad Laboratories stock price for the last 52 weeks is 305.06.
| Bio-Rad Laboratories Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2026 | 303.8017 | 305.2700 | 390.3400 | 241.7100 | 382.4100 | 26.21% |
| 2025 | 280.3724 | 326.1600 | 367.0000 | 216.5600 | 302.9900 | -7.77% |
| 2024 | 319.1788 | 327.9900 | 374.2800 | 263.9700 | 328.5100 | 1.74% |
| 2023 | 393.2294 | 422.4300 | 503.0000 | 269.3700 | 322.8900 | -23.21% |
| 2022 | 505.9841 | 735.4200 | 735.4200 | 351.7100 | 420.4900 | -44.35% |
| 2021 | 675.8090 | 575.2600 | 825.7700 | 547.0100 | 755.5700 | 29.61% |
| 2020 | 472.1816 | 372.1600 | 643.4500 | 320.0100 | 582.9400 | 57.54% |
| 2019 | 312.5641 | 228.0800 | 374.2000 | 224.3000 | 370.0300 | 59.34% |
| 2018 | 277.5328 | 241.4200 | 326.1500 | 220.1000 | 232.2200 | -2.70% |
| 2017 | 219.5758 | 182.9100 | 271.3000 | 182.9100 | 238.6700 | 30.94% |
| 2016 | 149.1690 | 136.1900 | 183.4600 | 123.9300 | 182.2800 | 31.46% |
| 2015 | 137.5260 | 120.3500 | 151.9300 | 113.7700 | 138.6600 | 15.01% |
| 2014 | 120.8765 | 122.6500 | 133.7300 | 106.4800 | 120.5600 | -2.47% |
| 2013 | 118.6682 | 107.4600 | 126.0000 | 107.4600 | 123.6100 | 17.67% |
| 2012 | 102.7218 | 98.0800 | 114.2500 | 92.3000 | 105.0500 | 9.38% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $10.135B | $2.583B |
| Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $177.122B | 19.46 |
| Medtronic (MDT) | Ireland | $118.448B | 16.19 |
| Stryker (SYK) | United States | $109.226B | 20.41 |
| EssilorLuxottica (ESLOY) | France | $77.130B | 0.00 |
| Boston Scientific (BSX) | United States | $63.636B | 13.68 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.867B | 0.00 |
| Medline (MDLN) | United States | $43.372B | 0.00 |
| Agilent Technologies (A) | United States | $43.330B | 25.36 |
| ResMed (RMD) | United States | $32.926B | 20.43 |
| GE HealthCare Technologies (GEHC) | United States | $28.678B | 13.71 |
| Koninklijke Philips (PHG) | Netherlands | $24.307B | 12.95 |
| Terumo (TRUMY) | Japan | $21.197B | 20.24 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.460B | 11.41 |
| Baxter (BAX) | United States | $12.165B | 11.48 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.674B | 0.00 |
| Demant (WILYY) | Denmark | $10.101B | 0.00 |
| Insulet (PODD) | United States | $9.751B | 23.95 |
| Sunny Optical Technology (SNPTF) | China | $9.508B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.562B | 20.19 |
| Raia Drogasil SA - (RADLY) | $5.056B | 0.00 | |
| BillionToOne (BLLN) | United States | $4.889B | 148.01 |
| Haemonetics (HAE) | United States | $4.834B | 21.21 |
| DiaSorin S.p.A (DSRLF) | Italy | $4.705B | 0.00 |
| Envista Holdings (NVST) | United States | $4.011B | 16.99 |
| ICU Medical (ICUI) | United States | $3.890B | 23.23 |
| AtriCure (ATRC) | United States | $2.907B | 248.43 |
| Neogen (NEOG) | United States | $2.737B | 48.27 |
| Curaleaf Holdings (CURLD) | Canada | $2.388B | 0.00 |
| Curaleaf Holdings (CURLF) | United States | $2.330B | 0.00 |
| Trulieve Cannabis (TRLV) | United States | $2.224B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.220B | 10.60 |
| GN Store Nord (GNNDY) | Denmark | $2.165B | 0.00 |
| Perrigo (PRGO) | Ireland | $1.879B | 5.42 |
| LeMaitre Vascular (LMAT) | United States | $1.838B | 29.55 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $1.798B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.776B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.767B | 225.69 |
| Green Thumb Industries (GTBIF) | United States | $1.443B | 15.40 |
| Kestra Medical Technologies (KMTS) | United States | $1.434B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.433B | 11.00 |
| Omeros (OMER) | United States | $1.255B | 6.35 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.119B | 0.00 |
| CeriBell (CBLL) | United States | $0.940B | 0.00 |
| InMode (INMD) | Israel | $0.838B | 11.66 |
| AdaptHealth (AHCO) | United States | $0.806B | 16.89 |
| VAREX IMAGING (VREX) | United States | $0.778B | 17.10 |
| Glass House Brands (GLAS) | United States | $0.753B | 0.00 |
| QuidelOrtho (QDEL) | United States | $0.739B | 7.98 |
| Valneva SE (VALN) | France | $0.623B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.549B | 0.00 |
| Brainsway (BWAY) | Israel | $0.541B | 30.59 |
| Tilray Brands (TLRY) | Canada | $0.535B | 0.00 |
| Evolus (EOLS) | United States | $0.528B | 0.00 |
| Cerus (CERS) | United States | $0.510B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.498B | 0.00 |
| Vireo Growth (VREOD) | United States | $0.451B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.441B | 0.00 |
| Verano Holdings (VRNOD) | United States | $0.425B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.411B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.395B | 8.28 |
| Cresco Labs (CRLBF) | United States | $0.367B | 0.00 |
| SNDL (SNDL) | Canada | $0.355B | 0.00 |
| Village Farms (VFF) | Canada | $0.346B | 15.72 |
| Viemed Healthcare (VMD) | United States | $0.341B | 24.83 |
| Sanara MedTech (SMTI) | United States | $0.323B | 159.54 |
| TriSalus Life Sciences (TLSI) | United States | $0.304B | 0.00 |
| MacroGenics (MGNX) | United States | $0.260B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.248B | 13.21 |
| OraSure Technologies (OSUR) | United States | $0.240B | 0.00 |
| High Tide (HITI) | Canada | $0.239B | 53.80 |
| Utah Medical Products (UTMD) | United States | $0.236B | 22.58 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| TerrAscend (TSNDF) | Canada | $0.201B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.192B | 0.00 |
| Exagen (XGN) | United States | $0.188B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Jin Medical (ZJYL) | China | $0.155B | 0.00 |
| Organigram Global (OGI) | Canada | $0.149B | 0.00 |
| Quanterix (QTRX) | United States | $0.138B | 0.00 |
| Apyx Medical (APYX) | United States | $0.127B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| FitLife Brands (FTLF) | United States | $0.088B | 11.51 |
| ImmuCell (ICCC) | United States | $0.087B | 120.12 |
| Jushi Holdings (JUSHF) | United States | $0.083B | 0.00 |
| Accendra Health (ACH) | United States | $0.082B | 4.65 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| InterCure (INCR) | Israel | $0.058B | 0.00 |
| Hongchang (HCIL) | China | $0.055B | 0.00 |
| Biote (BTMD) | United States | $0.048B | 3.94 |
| Nephros (NEPH) | United States | $0.047B | 39.09 |
| Veru (VERU) | United States | $0.040B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.036B | 17.58 |
| United-Guardian (UG) | United States | $0.033B | 13.20 |
| Rockwell Medical (RMTI) | United States | $0.031B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.022B | 0.00 |
| Modular Medical (MODD) | United States | $0.019B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.018B | 0.00 |
| Bonk (BNKK) | United States | $0.010B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.001B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.000B | 0.00 |
| INLIF (INLF) | China | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |